Muscular dystrophy (MD) is a group of diseases that gradually cause a person to lose muscle mass and lead to weakness. In MD, genetic mutations alter the formation of muscles, leading to muscle damage. It causes dystrophin deficiency, ultimately leading to muscle atrophy and fibrosis.
Muscular dystrophy affects various muscles based on the type of dystrophy, and alters the ability to move, walk, breathe, and perform daily activities. In addition to these activities, it also alters the heart muscles.
With current therapies focusing on mitigating the illness, stem cell therapy is emerging as a promising approach in the treatment of muscular dystrophies.
Types of Muscular Dystrophies
There are 30 different types of MD, and the most common types are:
- Duchenne Muscular Dystrophy: It is a type of dystrophy that is more common in boys compared to girls. The symptoms seen are muscle pain and stiffness, difficulty in moving, and frequent falls, among others. Over time, as the disease progresses, it also affects the heart and lungs.
- Becker Muscular Dystrophy: It is the second most common type of MD, and the symptoms are similar to those of Duchenne Muscular Dystrophy, but are less serious. It is commonly encountered in teenage years.
- Myotonic Dystrophy: In this form of dystrophy, the muscles cannot relax after contractions and usually affect the neck and facial muscles. Because of continued contractions, the symptoms seen are swanlike necks and drooping eyelids.
- Distal MD: This type of dystrophy affects various parts, such as the arms, hands, legs, and feet.
- Congenital MD: As the name suggests, congenital dystrophy is present since birth. It leads to symptoms such as muscle weakness and joint stiffness. It also causes problems such as breathing issues, intellectual and learning difficulties, among others.
The other less common types of muscular dystrophies are Emery-Dreifuss Muscular Dystrophy (EDMD), Facioscapulohumeral Muscular Dystrophy (FSHD), Limb-girdle Muscular Dystrophy (LGMD), and Oculopharyngeal Muscular Dystrophy (OPMD).
Challenges of conventional treatment strategies
- Medications such as corticosteroids used in the MD improve muscle strength, but prolonged use of such medications can increase the risk of adverse effects.
- Rehabilitation strategies and exercises do not serve any purpose to patients suffering from any fracture or who are bedridden.
- Current treatment for MD focuses on managing the symptoms, but it doesn’t target the underlying cause.
- In severe cases, the clinician resorts to the surgical option, which can cause undue pain and suffering to the patient.
Because of the challenges faced by conventional treatment strategies, it is important to consider stem cell treatment.
Stem cell therapy for Muscular Dystrophy
The paradigm shift from conventional treatment options to stem cell treatment has influenced a change in the field. Through stem cell therapy, it is possible to create an ecosystem where patients with MD receive the best care.
The therapeutic strategy of stem cell treatment for muscular dystrophy is to enhance the regenerative potential of muscles damaged due to the disease.
Skeletal muscle regeneration
The implantation of stem cells stimulates the satellite cells, which causes the proliferation and differentiation of the myoblasts. Myoblasts join together and form myofibers that contribute to the regeneration of muscles.
Mechanism of stem cells in MD
- The implantation of stem cells regenerates the damaged muscle cells and muscle fibers. It also reduces the progression of fibrosis by suppressing TGF-β1.
- Stem cells promote repair of muscles by decreasing the levels of inflammatory cytokines such as Tumor necrosis factor-α (TNF-α), Interleukin-1β (IL-1β), and IL-6.
- They enhance the process of myofibrogenesis and accelerate the recovery and function of muscles. Furthermore, they also increase the expression of dystrophin.
- Stem cells also enhance the formation of new blood vessels in the damaged muscles.
- They mitigate the symptoms of muscle dystrophy and maintain muscle homeostasis.
What are the benefits of post-stem cell treatment?
- Enhanced motor skills
- Speech improvement
- Enhanced perception
- Enhanced reflex
- Rejuvenation of the body
Exosomes in the treatment of MD
Exosomes derived from stem cells consist of components such as growth factors, lipids, microRNAs, cytokines, and mRNAs. These components released by exosomes act on damaged muscles and regenerate them.
Exosomes trigger cell proliferation and suppress apoptosis of myogenic cells. They regenerate the damaged muscles, alleviate inflammation, reduce fibrosis of muscles, and enhance muscle functions.
Role of novel K884 drug in MD
Research by McGill University revealed that the drug K884 is effective in treating Duchenne Muscular Dystrophy. The drug K884 was initially developed for the treatment of cancer and metabolic disorders, but has been repurposed for treating Duchenne MD.
The drug K884 inhibits two enzymes: Protein tyrosine phosphatase non-receptor type 1 (PTPN1) and type 2 (PTPN2). The two enzymes PTPN1 and PTPN2 are responsible for regulating signaling pathways for proliferation and differentiation. With the inhibition of PTPN1 and PTPN2, K884 enhances the proliferation of stem cells into muscle cells, thereby promoting muscle recovery.
Therefore, K884 enhances stem cells, triggers muscle repair, and improves overall quality of life.
Latest research insights into Duchenne Muscular Dystrophy (DMD)
DMD is a disease that causes a genetic mutation in the dystrophin gene. The genetic mutations disrupt dystrophin into mRNA fragments. Until now, it was known that the lack of dystrophin is compensated for by enhanced utrophin production.
But now the scientists from the Max Planck Institute for Heart and Lung Research showed that the transcriptional adaptation is the mechanism by which mRNA fragments of dystrophin enhance utrophin production.
The researchers suggest that it is now feasible to control the utrophin production by regulating the disruption of dystrophin into mRNA fragments. The discovery of this mechanism might open the path for the development of new therapeutic strategies in the treatment of DMD.
Outcomes post-stem cell therapy |
|
| 1. | Decreased muscle pain and stiffness |
| 2. | Reduced flares of muscle stiffness |
| 3. | Enhanced control of muscles |
| 4. | Enhanced movement |
| 5. | Better social balance |
Concluding remarks
Although conventional therapies manage the condition, no existing treatment provides a cure. So this blog aims to highlight the enormous potential of stem cell therapy in treating muscular dystrophies. Stem cell therapy has proven its potential, as it targets the root cause of the disease and provides a curative option.
The capability of stem cells to regenerate damaged muscle tissue makes them a viable option in MD. And with ongoing research and technological advancements, stem cell therapy has the ability to develop into an effective treatment option.
FAQs
Q: Define Muscular Dystrophy.
Muscular dystrophy (MD) is a group of diseases that gradually cause a person to lose muscle mass and lead to weakness. In MD, genetic mutations alter the formation of muscles, leading to muscle damage. It causes dystrophin deficiency, ultimately leading to muscle atrophy and fibrosis.
Q: What are the common types of Muscular dystrophies?
The common types of muscular dystrophies are Duchenne Muscular Dystrophy (DMD), Becker Muscular Dystrophy (BMD), Myotonic Dystrophy, Distal Muscular Dystrophy, and Congenital Muscular Dystrophy (CMD).
Q: Can stem cells cure Muscular dystrophy?
Stem cells cure muscular dystrophies by proliferating and regenerating the damaged muscles, alleviating inflammation, suppressing apoptosis of myogenic cells, reducing fibrosis of muscles, and enhancing muscle functions.
Q: What are the outcomes following stem cell treatment?
The outcomes following stem cell treatment are decreased muscle pain and stiffness, reduced flares of muscle stiffness, enhanced control of muscles, enhanced movement, and better social balance.
Recent Comments